Table 2.
IVF parameters and pregnancy outcomes of patients with endometriosis and patients in the control group. Values are shown as mean ± SD or percentage (%).
| Endometriosis | Control | p Value | |
|---|---|---|---|
| Group (n = 155) | Group (n = 969) | ||
| Retrieved oocytes (n) | 7.0 ± 4.3 | 9.7 ± 6.4 | <0.0001 * |
| Metaphase II oocytes (n) | 4.8 ± 3.5 | 6.9 ± 5.0 | <0.0001 * |
| Oocyte maturity rate (%) | 68.6 ± 24.5 | 71.1 ± 23.7 | 0.2 |
| Embryos (n) | 3.5 ± 2.9 | 4.8 ± 3.9 | 0.0006 * |
| Cleavage rate (%) | 71.3 ± 29.2 | 68.4 ± 26.6 | 0.1 |
| Transferred embryos (n) | 1.2 ± 0.8 | 1.3 ± 0.7 | 0.6 |
| Top-quality embryos (n) | 0.5 ± 0.8 | 0.7 ± 1.1 | 0.01 * |
| Top-quality embryos (%) | 12.8 ± 21.7 | 16.3 ± 25.2 | 0.06 |
| Frozen embryos (n) | 0.8 ± 1.6 | 1.5 ± 2.2 | 0.0003 * |
| Usable embryos (%) | 61.6 ± 33.6 | 66.3 ± 28.1 | 0.1 |
| Embryos with delayed cleavage (n) | 0.15 ± 0.39 | 0.12 ± 0.39 | 0.2 |
| Implantation rate (%) | 17.3 | 23.6 | 0.05 |
| Live birth rate/cycle (%) | 16.1 | 23.2 | 0.05 |
| Frozen embryo transfers (n) | 0.32 | 0.55 | 0.001 * |
| Cumulative live birth rate/patient (%) | 32.1 | 50.7 | 0.001 * |
* significant.